<VariationArchive VariationID="1399626" VariationName="NM_015627.3(LDLRAP1):c.604del (p.Ser202fs)" VariationType="Deletion" Accession="VCV001399626" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1365983" VariationID="1399626">
      <GeneList>
        <Gene Symbol="LDLRAP1" FullName="low density lipoprotein receptor adaptor protein 1" GeneID="26119" HGNC_ID="HGNC:18640" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="25543606" stop="25590400" display_start="25543606" display_stop="25590400" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="25870075" stop="25895376" display_start="25870075" display_stop="25895376" Strand="+" />
          </Location>
          <OMIM>605747</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015627.3(LDLRAP1):c.604del (p.Ser202fs)</Name>
      <CanonicalSPDI>NC_000001.11:25563140:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p36.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="25563141" stop="25563141" display_start="25563141" display_stop="25563141" variantLength="1" positionVCF="25563140" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="25889632" stop="25889632" display_start="25889632" display_stop="25889632" variantLength="1" positionVCF="25889631" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>S202fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_276" sequenceAccession="LRG_276">
            <Expression>LRG_276:g.24557del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.25889632del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.25889632del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.25563141del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.25563141del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008932.1" sequenceAccession="NG_008932" sequenceVersion="1" change="g.24557del">
            <Expression>NG_008932.1:g.24557del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015627.3" sequenceAccession="NM_015627" sequenceVersion="3" change="c.604del" MANESelect="true">
            <Expression>NM_015627.3:c.604del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056442.2" sequenceAccession="NP_056442" sequenceVersion="2" change="p.Ser202fs">
            <Expression>NP_056442.2:p.Ser202fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2044386296" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015627.3(LDLRAP1):c.604del (p.Ser202fs) AND Hypercholesterolemia, familial, 4" Accession="RCV001893841" Version="5">
        <ClassifiedConditionList TraitSetID="1313">
          <ClassifiedCondition DB="MedGen" ID="C1863512">Hypercholesterolemia, familial, 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11326085</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12464675</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1313" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1726" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypercholesterolemia, familial, 4</ElementValue>
                <XRef ID="MONDO:0011374" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypercholesterolemia, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE, 1</ElementValue>
                <XRef Type="MIM" ID="603813" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE, 2</ElementValue>
                <XRef Type="MIM" ID="603813" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FHCB1</ElementValue>
                <XRef Type="MIM" ID="603813" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FHCB2</ElementValue>
                <XRef Type="MIM" ID="603813" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">FHCL4</ElementValue>
                <XRef Type="MIM" ID="603813" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ARH1</ElementValue>
                <XRef Type="MIM" ID="603813" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ARH2</ElementValue>
                <XRef Type="MIM" ID="603813" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Familial hypercholesterolemia (FH) is characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) that leads to atherosclerotic plaque deposition in the coronary arteries and proximal aorta at an early age and increases the risk of premature cardiovascular events such as angina and myocardial infarction; stroke occurs more rarely. Xanthomas (cholesterol deposits in tendons) may be visible in the Achilles tendons or tendons of the hands and worsen with age as a result of extremely high cholesterol levels. Xanthelasmas (yellowish, waxy deposits) can occur around the eyelids. Individuals with FH may develop corneal arcus (white, gray, or blue opaque ring in the corneal margin as a result of cholesterol deposition) at a younger age than those without FH. Individuals with a more severe phenotype, often as a result of biallelic variants, can present with very significant elevations in LDL-C (&gt;500 mg/dL), early-onset coronary artery disease (CAD; presenting as early as childhood in some), and calcific aortic valve disease.</Attribute>
                <XRef ID="NBK174884" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18614" />
                <XRef ID="18614" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24404629</ID>
                <ID Source="BookShelf">NBK174884</ID>
              </Citation>
              <Citation Type="Position Statement" Abbrev="CSANZ, 2016">
                <URL>https://www.csanz.edu.au/wp-content/uploads/2017/07/Familial-Hypercholesterolaemia_ratified_-25-Nov-2016.pdf</URL>
                <CitationText>The Cardiac Society of Australia and New Zealand, Diagnosis and Management of Familial Hypercholesterolaemia â€“ Position Statement</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Familial-Hypercholesterolemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APOB, LDLR, PCSK9 Pathogenic Variants (Familial Hypercholesterolemia), 2019</CitationText>
              </Citation>
              <XRef ID="391665" DB="Orphanet" />
              <XRef ID="C1863512" DB="MedGen" />
              <XRef ID="MONDO:0011374" DB="MONDO" />
              <XRef Type="MIM" ID="603813" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4193512" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="9294583|MedGen:C1863512" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002170026" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11326085</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12464675</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser202Profs*2) in the LDLRAP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLRAP1 are known to be pathogenic (PMID: 11326085, 12464675). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with LDLRAP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1399626). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLRAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.25889632del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1863512" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4193512" TraitType="Disease" MappingType="XRef" MappingValue="C1863512" MappingRef="MedGen">
        <MedGen CUI="C1863512" Name="Hypercholesterolemia, familial, 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

